Claude L.
- Country
- France
- Department
- Oncologie Médicale
Research Overview
- Evaluation of Pembrolizumab and Axitinib Combination Versus Sunitinib Monotherapy in First-line Treatment of Metastatic Renal Cell Carcinoma
- Phase III Randomized Trial of Atezolizumab Plus BCG Versus BCG Alone in High-Risk Non-Muscle Invasive Bladder Cancer Patients
- Randomized Study of Zoledronic Acid Monohydrate in Combination Chemotherapy for High-Grade Osteosarcoma in Pediatric and Adult Patients
Data & Insights
Has run more than one trial at 19 of 100 partner sites.
Specializations
Thoracic Oncology
Claude LINASSIER is involved in clinical research on non-small cell lung cancer, small cell lung cancer, and thoracic malignancies, with attention to locally advanced, metastatic, and resected disease. The oncology portfolio also includes pleural mesothelioma and advanced lung cancer subtypes defined by molecular features.
- Non-small cell lung cancer
- Small cell lung cancer
- Pleural mesothelioma
- Advanced thoracic malignancies
The therapeutic focus extends across targeted treatment strategies, immunotherapy-based care, and perioperative or maintenance approaches in lung cancer.
Hematologic Malignancies
His research landscape includes acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. He is also linked to studies in myelofibrosis, plasma cell disorders, and other B-cell malignancies.
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Multiple myeloma
His therapeutic interest is centered on blood cancer treatment, including novel immunotherapies, combination regimens, and disease control in relapsed or high-risk settings.
Breast, Gastrointestinal, and Genitourinary Cancers
Claude LINASSIER contributes to research in breast cancer, colorectal cancer, pancreatic cancer, gastric cancer, hepatocellular carcinoma, prostate cancer, and urothelial carcinoma. His trial activity also covers head and neck cancer, esophageal cancer, ovarian cancer, and renal cell carcinoma.
- Breast cancer
- Colorectal cancer
- Prostate cancer
- Urothelial carcinoma
The therapeutic emphasis spans advanced solid tumors, biomarker-driven treatment selection, and strategies for metastatic or locally advanced disease.
Autoimmune, Inflammatory, and Pulmonary Disease
His clinical research also covers ulcerative colitis, Crohn's disease, rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, and vasculitis. In pulmonary medicine, his interests include idiopathic pulmonary fibrosis, interstitial lung disease, pulmonary hypertension, sarcoidosis, and severe asthma.
- Inflammatory bowel disease
- Rheumatologic disease
- Interstitial lung disease
- Pulmonary hypertension
These areas reflect a therapeutic focus on immune-mediated disease control, chronic inflammation, and progressive respiratory disorders.
Cardiovascular, Renal, and Critical Care Medicine
Claude LINASSIER is involved in studies of atherosclerotic cardiovascular disease, heart failure, myocardial infarction, stroke, hypertension, chronic kidney disease, and kidney transplantation. His research profile also includes sepsis, intensive care, and acute kidney injury.
- Cardiovascular disease
- Chronic kidney disease
- Kidney transplantation
- Sepsis
His therapeutic interests include prevention of vascular events, renal protection, transplant-related care, and management of acute organ dysfunction in critical illness.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.